[1]
“Efficacy and Safety of SGLT2 Inhibitors in Non-Diabetic Patients with Heart Failure: A Systematic Review and Meta-Analysis”, VER, vol. 8, no. 4s, pp. 395–401, Oct. 2025, doi: 10.64149/J.Ver.8.4s.395-401.